4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study
    Meeting Abstract

    Myers, A. P.; Filiaci, V. L.; Zhang, Y. P.; Pearl, M.; Behbakht, K.; Makker, V.; Hanjani, P.; Zweizig, S.; Burke, J. J.; Downey, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907
    Meeting Abstract

    Muss, H. B.; Berry, D. A.; Cirrincione, C. T.; Theodoulou, M.; Hurria, A.; Cohen, H. J.; Partridge, A.; Norton, L.; Hudis, C. A.; Winer, E. P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Investigation of intrapatient heterogeneity in the tumor infiltrating T cell repertoire in patients with metastatic melanoma treated with pembrolizumab
    Meeting Abstract

    Munhoz, R. R.; Merghoub, T.; Emerson, R. O.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The role of LHRH agonists in ovarian function preservation in premenopausal women undergoing chemotherapy for early stage breast cancer: A systematic review and meta-analysis
    Meeting Abstract

    Munhoz, R. R.; Pereira, A. A. L.; Sasse, A. D.; Hoff, P. M.; Traina, T. A.; Hudis, C. A.; Marques, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy (NACT) selection for advanced stage ovarian cancer (AOC) at a comprehensive cancer center
    Meeting Abstract

    Mueller, J. J.; Alvi, F. A.; El Haraki, A. S.; Eriksson, A. G.; Zhou, Q.; Iasonos, A.; O'Cearbhaill, R. E.; Chi, D.; Abu Rustum, N.; Zivanovic, O.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Long-term risks for chronic medical conditions and premature mortality in survivors of pediatric soft tissue sarcoma: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Mueller, E. L.; Hutchinson, R. J.; Goodman, P.; Leisenring, W. M.; Sklar, C. A.; Hudson, M. M.; Ness, K. K.; Armstrong, G. T.; Robison, L. L.; Stovall, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Randomized phase II, three-arm trial of lenvatinib (LEN), everolimus (EVE), and LEN+EVE in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Motzer, R.; Hutson, T.; Glen, H.; Michaelson, D.; Molina, A. M.; Eisen, T.; Jassem, J.; Zolnierek, J.; Maroto, P.; Mellado, B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Motzer, R.; Alyasova, A.; Ye, D. W.; Karpenko, A.; Li, H. Z.; Alekseev, B. Y.; Xie, L. P.; Kurteva, G. P.; Kowalyszyn, R. D.; Neron, Y.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy analysis of a phase III study of androgen deprivation therapy (ADT) +/- docetaxel (D) for men with biochemical relapse (BCR) after prostatectomy
    Meeting Abstract

    Morris, M. J.; Hilden, P.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Dayan, E. S.; Filipenko, J.; Acosta, I.; Heller, G.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effects of radium-223 dichloride (Ra-223) with docetaxel (D) vs D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial
    Meeting Abstract

    Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Loriot, Y.; Fizazi, K.; Pandit-Taskar, N.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save